HIV treatment should be started earlier for most, but challenges remain

Noting "French researchers have identified 14 adults" who appear to have been functionally cured of HIV after beginning treatment "within a couple of months of infection" and continuing treatment "for one to seven and a half years" before stopping, a New York Times editorial writes, "The researchers estimate that as many as 15 percent of adults who start treatment early and continue for at least a year may then be able to stop their drug regimen and live healthily without the drugs." The newspaper continues, "Although the study was small, the findings suggest that treatment should be started earlier for most people, a difficult feat without a lot more testing to identify who is infected and prompt treatment of those who test positive." The editorial writes, "The findings also suggest that many people taking antiviral drugs may be able to stop safely, provided doctors can find some sure way to identify them" (3/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses